Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors

Journal of Cellular Biochemistry

Volumn 72, Issue 2, 1999, Pages 251-261

  Shalhoub, Victoria ^a   Faust, Judy ^a   Boyle, William J ^a   Dunstan, Colin R ^a   Kelley, Mike ^a   Kaufman, Steve ^a   Scully, Sheila ^a   Van, Gwyneth ^a   Lacey, David L ^a  

^a AMGEN INC   (United States)

Author keywords

Bone; Multinucleated cells; Resorption; Vitronectin receptor osteoprotegerin

Indexed keywords

ACID PHOSPHATASE; CALCITRIOL; CATHEPSIN K; COLONY STIMULATING FACTOR 1; HYDROCORTISONE; LIGAND; MESSENGER RNA; OSTEOPROTEGERIN; PLASTIC; RECEPTOR PROTEIN; TARTARIC ACID; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MONONUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; STEM CELL;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CARRIER PROTEINS; CATHEPSINS; CELL DIFFERENTIATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MICE; MONOCYTES; OSTEOCLASTS; OSTEOPROTEGERIN; PEPTIDYLPROLYL ISOMERASE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS;

EID: 0033555651     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990201)72:2<251::AID-JCB9>3.0.CO;2-W     Document Type: Article

References (32)

1. Abe E, Tanaka H, Ishimi Y, Miyaura C, Hayashi T, Nagasawa H, Tomida M, Yamaguchi Y, Hozumi M, Suda T. 1986. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 83:5958-5962.
2. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux, ER, Teepe MC, DuBose RF, Cosman D, Galibert L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-178.
3. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Caparelli C, Scully S, Tan H-L, Xu W, Lacey DL, Boyle WJ, Simonet WS. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268.
4. Coccia PF, Krivit W, Cervenka J, et al. 1980. Successful bone marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 302:701-708.
5. Faust J, Lacey DL, Hunt P, Burgess TL, Scully S, Van G, Eli A, Qian Y-x, Shalhoub V. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem (in press).
6. Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H. 1990. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5:781-789.
7. Fujikawa Y, Quinn JMW, Sabokbar A, McGee JO'D, Athanasou NA. 1996. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058-4060.
8. Fuller K, Gallagher AC, Chambers TJ. 1991. Osteoclast resorption-stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix. Biochem Biophys Res Commun 181:67-73.
9. Hagenaars CE, van der Kraan AAM, Kawilarang-de Haas EWM, Visser JWM, Nijweide PJ. 1989. Osteoclast formation from cloned pluripotent hemopoietic stem cells. Bone Miner 6:179-189.
10. Hattersley G, Chambers TJ. 1989. Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro. J Cell Physiol 140:478-482.
11. Hentunen TA, Cunningham NS, Vuolteenaho O, Reddi AH, Vaananen HK. 1994. Osteoclast recruiting activity in bone matrix. Bone Miner 25:183-198.
12. Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE. 1972. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 177:793-795.
13. Kahn AJ Simmons DJ, 1975. Investigation of the cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature 258:325-327.
14. Kodama H, Nose M, Niida S, Yamasaki A. 1991. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med 173:1291-1294.
15. Kumegawa M. 1989. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74:1295.
16. Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Kiura K, Hakeda Y, Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Caparelli C, Eli A, Qian Y-X, Kaufman S, Sarosi I, Shalhoub V, Senaldi, G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
17. Lee MY, Eyre DR, Osborne WRA. 1991. Isolation of a murine osteoclast colony-stimulating factor. Proc Natl Acad Sci USA 88:8500-8504.
18. Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R. 1996. Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci USA 93:10785-10790.
19. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. 1998. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
20. Nesbitt SA, Horton MA. 1997. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276:266-270.
21. Purton LE, Lee MY, Torok-Storb B. 1996. Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nomnobilized blood. Blood 87:1802-1808.
22. Rodan GA, Martin, TJ. 1981. Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif Tissue Int 33:349-351.
23. Salo J, Lehenkari P, Mulari M, Metsikko K, Vaananen, HK. 1997. Removal of osteoclast bone resorption products by transcytosis. Science 276:270-273.
24. Sheven BAA, Visser JWM, Nijwiede PJ. 1986. In vitro osteoclast generation from different marrow fractions including a highly enriched haemopoietic stem cell population. Nature 321:79-81.
25. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Luthy R, Nguyen HQ, Shimomoto G, DeRose M, Elliott, R, Colombero A, Tan H-L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Amgen EST program, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
26. Walker DG. 1973. Osteopetrosis cured by temporary parabiosis. Science 180:875.
27. Walker DG. 1975. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through the use of bone marrow mononuclear phagocytes. J Exp Med 142:651-663.
28. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER. 1990, Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87:4828-4832.
29. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlet FS III, Frankel W, Lee S-Y, Choi Y. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J Biol Chem 272:25190-25194.
30. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
31. Yoneda T, Kato I, Bonewald LF, Burgess WH, Mundy GR. 1993. A novel cytokine with osteoclastopoietic activity. J Periodont Res 28:521-522.
32. Yoshida H, Hayashi S-I, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S-I. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.